clinical trial · NCT06513104
A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause
Novo Nordisk A/S·phase1·completed·n = 47
Diabetes Mellitus, Type 2NNC0519-0130Levonorgestrel + EthinylestradiolParacetamol
brief summary
The purpose of the study is to investigate if NNC0519-0130 affects the blood levels of a birth control pill that contains the two hormones ethinylestradiol and levonorgestrel. The study will also look into if NNC0519-0130 affects how fast stomach is emptied. Participants will get the new study medicine NNC0519-0130 and will also get birth control pills and paracetamol. The study will last for about 35 weeks.
started
Jul 18, 2024
primary completion
Sep 10, 2025
completion
Sep 30, 2025
last updated
Mar 12, 2026
official title
Investigation of the Effect of NNC0519-0130 on the Pharmacokinetics of an Oral Combination Contraceptive (Ethinylestradiol and Levonorgestrel) and Gastric Emptying in Healthy Postmenopausal Females
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol